首页> 美国卫生研究院文献>Annals of Laboratory Medicine >Hepcidin and Neutrophil Gelatinase-Associated Lipocalin as a Biomarker for Acute Kidney Injury Linked Iron Metabolism
【2h】

Hepcidin and Neutrophil Gelatinase-Associated Lipocalin as a Biomarker for Acute Kidney Injury Linked Iron Metabolism

机译:铁调素和中性粒细胞明胶酶相关的脂蛋白作为急性肾脏损伤相关铁代谢的生物标志物。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute kidney injury (AKI) is one of the serious complications of cardiac surgery and can be a significant life-threatening factor associated with high morbidity and mortality [ , , ]. There are multiple damaging mechanisms of cardiac surgery-induced AKI, such as ischemia and reperfusion injury, inflammation, and oxidative stress [ ]. Among various candidate biomarkers and underlying mechanisms, hepcidin and iron metabolism in AKI are recently attracting the attention of researchers as one of the main mechanisms causing renal damage in various clinical conditions [ , , , , ]. However, the role of iron regulation in cardiac surgery still remains unclear [ ].
机译:急性肾损伤(AKI)是心脏外科手术的严重并发症之一,可能是与高发病率和高死亡率相关的重大生命威胁因素[,]。心脏手术引起的AKI有多种破坏机制,例如缺血和再灌注损伤,炎症和氧化应激[]。在各种候选生物标志物和潜在机制中,AKI中的铁调素和铁代谢最近引起了研究人员的注意,因为它是在各种临床条件下引起肾脏损害的主要机制之一[,,,]。然而,铁调节在心脏手术中的作用仍不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号